Daniel Meruelo

Ovarian cancer biotech Cynvec inches forward in $10 million round

New York-based biotech company, Cynvec, is currently raising capital to aid in the development of a vaccine designed to treat ovarian cancer.

By Nicole Oran

A Personalized Approach to Medication Nonadherence

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.

BioPharma

BioLabs Pegasus Park Cultivates Life Science Ecosystem

Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.